Motif Neurotech, a startup from Houston, has received approval from the US Food and Drug Administration to conduct a human study on a new brain implant designed to help people with severe depression. This small device, about the size of a blueberry, is implanted in the skull and uses electrical stimulation to activate parts of the brain that are underactive in those with major depressive disorder. Unlike other brain-computer interfaces aimed at helping paralyzed individuals communicate, Motif’s device focuses on alleviating depression symptoms in patients who haven’t responded to medication. The implant can be placed in a quick outpatient procedure and is powered wirelessly, allowing patients to receive treatment at home. This innovation could offer a new hope for the nearly 3 million Americans with treatment-resistant depression.
QUESTION: How might advancements in brain-computer interfaces change the way we approach mental health treatment in the future?
A Brain Implant for Depression Is About to Be Tested in Humans
